Monika Katyal

Learn More
The human complement receptor 1 (C3b/C4b receptor, CD35, CR1), a polymorphic membrane bound glycoprotein, is differentially expressed on erythrocytes, eosinophils, monocytes, B and T-lymphocytes, dendritic cells and kidney podocytes. It also occurs in the plasma as soluble CR1 (sCR1) and in urine as urinary CR1 (uCR1). Different population studies have(More)
Complement receptor 1 (CR1) has gained much attention in recent years. The reason is manifold. Growing understanding on this protein has facilitated insight into the pathophysiology of autoimmune disorders. CR1, a polymorphic protein, is important as a complement regulatory protein, as well as a vehicle for immune complex clearance. Functional and clinical(More)
Complement receptor 1 (CR1, CD35, C3b/C4b receptor), a polymorphic membrane bound glycoprotein is important both as a complement regulatory protein, and as a vehicle for immune complex clearance. It is differentially expressed on erythrocytes, eosinophils, monocytes, B and T-lymphocytes, dendritic cells and kidney podocytes. It also occurs in the plasma as(More)
1-Amino-, 1-anilino- and 1-(2',4'-dinitroanilino)-4,4,6-trimethyl-1H,4H-2-pyrimidinethiols react with Pd(II) and Os(VIII), forming coloured complexes extractable into non-polar organic solvents. The optimum conditions for the complexation have been established. Beer's law is obeyed and by an extractive spectrophotometric procedure, microgram quantities of(More)
Alkyl and aryl substituted 4, 4, 6-trimethyl-(1H, 4H)2-pyrimidinethiols react selectively with palladium(II) in strong acids, forming yellow complexes (lambda(max) 430 nm) extractable into non-polar solvents. By an extractive spectrophotometric procedure, microgram amounts of palladium may be determined in the presence of milligram amounts of many species,(More)